Evidence map›Paper›PMID 26029982›Full record

ArticleCell cycle (Georgetown, Tex.)2015

Mutant lamin A links prophase to a p53 independent senescence program.

Olga Moiseeva, Frédéric Lessard, Mariana Acevedo-Aquino, Mathieu Vernier, Youla S Tsantrizos, Gerardo Ferbeyre

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Tying up loose ends: telomeres, genomic instability and lamins.Current opinion in genetics & development · 2016
    Review
  11. Article
  12. Article
  13. Trapping cells in senescence with a lamin cage.Cell cycle (Georgetown, Tex.) · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Olga Moiseevaa Département de Biochimie ; Université de Montréal ; C.P. 6128; Succ. Center-Ville; Montréal , QC Canada.
Frédéric Lessard
Mariana Acevedo-Aquino
Mathieu Vernier
Youla S Tsantrizos
Gerardo Ferbeyre
Université de Montréal · CAFaculty (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expression of oncogenes or short telomeres can trigger an anticancer response known as cellular senescence activating the p53 and RB tumor suppressor pathways. This mechanism is switched off in most tumor cells by mutations in p53 and RB signaling pathways. Surprisingly, p53 disabled tumor cells could be forced into senescence by expression of a mutant allele of the nuclear envelope protein lamin A. The pro-senescence lamin A mutant contains a deletion in the sequence required for processing by the protease ZMPSTE24 leading to accumulation of farnesylated lamin A in the nuclear envelope. In addition, the serine at position 22, a target for CDK1-dependent phosphorylation, was mutated to alanine, preventing CDK1-catalyzed nuclear envelope disassembly. The accumulation of this mutant lamin A compromised prophase to prometaphase transition leading to invaginations of the nuclear lamina, nuclear fragmentation and impaired chromosome condensation. Cells exited this impaired mitosis without cytokinesis and re-replicated their DNA ultimately arresting in interphase as polyploid cells with features of cellular senescence including increased expression of inflammatory gene products and a significant reduction of tumorigenicity in vivo.

Indexed as

CDC2 Protein KinaseCell Line, TumorCell ProliferationCellular SenescenceCyclin-Dependent KinasesHumansLamin Type AMembrane ProteinsMetalloendopeptidasesNeoplasmsNuclear EnvelopePhosphorylationRetinoblastoma ProteinTumor Suppressor Protein p53CDC2 Protein KinaseCDK1 protein, humanCyclin-Dependent KinasesLamin Type AMembrane ProteinsMetalloendopeptidasesRetinoblastoma ProteinTumor Suppressor Protein p53ZMPSTE24 protein, humanfarnesylationmitosisprogeriasenescenceZMPSTE24

Identifiers

PMID26029982
PMCPMC4614274
OpenAlexW1810350704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.